These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 11026642

  • 21. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection.
    Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F.
    Transplantation; 2018 Jul; 102(7):1075-1084. PubMed ID: 29620612
    [Abstract] [Full Text] [Related]

  • 22. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Larivière R.
    Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy of long-term cyclosporine treatment to prevent chronic renal allograft rejection in the rat.
    Paul LC, Chea R, Davidoff A, Benediktsson H.
    Transplant Proc; 1994 Oct; 26(5):2567-8. PubMed ID: 7940793
    [No Abstract] [Full Text] [Related]

  • 25. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
    Jolicoeur EM, Qi S, Xu D, Dumont L, Daloze P, Chen H.
    Transplantation; 2003 Jan 15; 75(1):54-9. PubMed ID: 12544871
    [Abstract] [Full Text] [Related]

  • 26. Oxidative stress in chronic renal allograft nephropathy in rats: effects of long-term treatment with carvedilol, BM 91.0228, or alpha-tocopherol.
    Göttmann U, Oltersdorf J, Schaub M, Knoll T, Back WE, van der Woude FJ, Braun C.
    J Cardiovasc Pharmacol; 2003 Sep 15; 42(3):442-50. PubMed ID: 12960691
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F, Ebbs A, Wynn C, Erickson L, Jang MS, Crews G, Fisniku O, Kobayashi M, Paul LC, Benediktsson H, Jiang AH.
    Transplantation; 2003 Apr 27; 75(8):1110-4. PubMed ID: 12717186
    [Abstract] [Full Text] [Related]

  • 29. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I, Khan ZA, Lian D, Jiang J, Zhong R, Garcia B, Chakrabarti S.
    Transplantation; 2006 Aug 15; 82(3):406-14. PubMed ID: 16906041
    [Abstract] [Full Text] [Related]

  • 30. Peritransplant treatment with cobalt protoporphyrin attenuates chronic renal allograft rejection.
    Bédard EL, Jiang J, Parry N, Wang H, Liu W, Garcia B, Kim P, Chakrabarti S, Buelow R, Zhong R.
    Transpl Int; 2005 Mar 15; 18(3):341-9. PubMed ID: 15730496
    [Abstract] [Full Text] [Related]

  • 31. The role of endothelin in the pathophysiology of renal impairment during acute liver rejection.
    Yokoi Y, Nakamura S, Serizawa A, Nishiyama R, Nishiwaki Y, Baba S.
    Transplantation; 1994 Jul 27; 58(2):144-9. PubMed ID: 8042233
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Endothelin-receptor antagonists in uremic cardiomyopathy.
    Wolf SC, Gaschler F, Brehm S, Klaussner M, Amann K, Risler T, Brehm BR.
    J Cardiovasc Pharmacol; 2000 Nov 27; 36(5 Suppl 1):S348-50. PubMed ID: 11078417
    [Abstract] [Full Text] [Related]

  • 34. Comprehensive immunohistological analysis of the endothelin system in human kidney grafts.
    Frank K, Zeier M, Gross ML, Waldherr R, Ritz E, Amann K.
    Nephrol Dial Transplant; 2006 May 27; 21(5):1365-72. PubMed ID: 16449275
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection.
    Diamond JR, Tilney NL, Frye J, Ding G, McElroy J, Pesek-Diamond I, Yang H.
    Transplantation; 1992 Oct 27; 54(4):710-6. PubMed ID: 1412763
    [Abstract] [Full Text] [Related]

  • 37. Contribution of early acute rejection episodes to chronic rejection in a rat kidney retransplantation model.
    Tullius SG, Nieminen M, Bechstein WO, Jonas S, Steinmüller T, Qun Y, Pratschke J, Graser E, Sinha P, Volk HD, Neuhaus P, Tilney NL.
    Kidney Int; 1998 Feb 27; 53(2):465-72. PubMed ID: 9461108
    [Abstract] [Full Text] [Related]

  • 38. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts.
    Hancock WH, Whitley WD, Tullius SG, Heemann UW, Wasowska B, Baldwin WM, Tilney NL.
    Transplantation; 1993 Sep 27; 56(3):643-50. PubMed ID: 8105570
    [Abstract] [Full Text] [Related]

  • 39. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection.
    Le Meur Y, Jose MD, Mu W, Atkins RC, Chadban SJ.
    Transplantation; 2002 Apr 27; 73(8):1318-24. PubMed ID: 11981428
    [Abstract] [Full Text] [Related]

  • 40. Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252.
    Bauersachs J, Braun C, Fraccarollo D, Widder J, Ertl G, Schilling L, Kirchengast M, Rohmeiss P.
    J Hypertens; 2000 Oct 27; 18(10):1507-14. PubMed ID: 11057440
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.